SE9003902D0 - Solid dosage forms of a drug - Google Patents

Solid dosage forms of a drug

Info

Publication number
SE9003902D0
SE9003902D0 SE9003902A SE9003902A SE9003902D0 SE 9003902 D0 SE9003902 D0 SE 9003902D0 SE 9003902 A SE9003902 A SE 9003902A SE 9003902 A SE9003902 A SE 9003902A SE 9003902 D0 SE9003902 D0 SE 9003902D0
Authority
SE
Sweden
Prior art keywords
dosage forms
drug
solid dosage
almokalant
complex
Prior art date
Application number
SE9003902A
Other languages
English (en)
Inventor
P J G Lundberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9003902A priority Critical patent/SE9003902D0/sv
Publication of SE9003902D0 publication Critical patent/SE9003902D0/sv
Priority to US07/629,877 priority patent/US5149523A/en
Priority to ZA919264A priority patent/ZA919264B/xx
Priority to TW080109239A priority patent/TW215057B/zh
Priority to IL100150A priority patent/IL100150A0/xx
Priority to NZ240731A priority patent/NZ240731A/en
Priority to YU186891A priority patent/YU186891A/sh
Priority to IE413791A priority patent/IE914137A1/en
Priority to APAP/P/1991/000338A priority patent/AP258A/en
Priority to MX9102325A priority patent/MX9102325A/es
Priority to EP91920708A priority patent/EP0560821A1/en
Priority to PCT/SE1991/000815 priority patent/WO1992010172A1/en
Priority to HU9301670A priority patent/HUT64217A/hu
Priority to JP4500117A priority patent/JPH06503312A/ja
Priority to AU89307/91A priority patent/AU8930791A/en
Priority to MA22639A priority patent/MA22355A1/fr
Priority to CA002097178A priority patent/CA2097178A1/en
Priority to CS931037A priority patent/CZ103793A3/cs
Priority to SK55693A priority patent/SK55693A3/sk
Priority to TNTNSN91117A priority patent/TNSN91117A1/fr
Priority to IS3788A priority patent/IS3788A7/is
Priority to MYPI91002267A priority patent/MY106776A/en
Priority to PT99719A priority patent/PT99719A/pt
Priority to CN91112789A priority patent/CN1063039A/zh
Priority to NO93932052A priority patent/NO932052L/no
Priority to FI932554A priority patent/FI932554A/fi
Priority to BG97851A priority patent/BG97851A/xx
Priority to LTIP1717A priority patent/LTIP1717A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
SE9003902A 1989-06-20 1990-12-07 Solid dosage forms of a drug SE9003902D0 (sv)

Priority Applications (28)

Application Number Priority Date Filing Date Title
SE9003902A SE9003902D0 (sv) 1990-12-07 1990-12-07 Solid dosage forms of a drug
US07/629,877 US5149523A (en) 1989-06-20 1990-12-19 Polystyrenesulfonate-drug complex and solid dosage forms thereof
ZA919264A ZA919264B (en) 1990-12-07 1991-11-22 Solid dosage forms of almokalant and processes for manufacture thereof
TW080109239A TW215057B (sv) 1990-12-07 1991-11-25
IL100150A IL100150A0 (en) 1990-12-07 1991-11-25 Solid dosage forms of almokalant and processes for manufacture thereof
NZ240731A NZ240731A (en) 1990-12-07 1991-11-26 Pharmaceutical dosage from of almokalant in a complex with polystyrene sulphonate
YU186891A YU186891A (sh) 1990-12-07 1991-11-27 Čvrsti oblici doziranja almokalata i postupci za njihovu proizvodnju
IE413791A IE914137A1 (en) 1990-12-07 1991-11-28 Solid dosage forms of almokalant and processes for¹manufacture thereof
APAP/P/1991/000338A AP258A (en) 1990-12-07 1991-12-02 Solid dosage forms of almokalant and processes for manufacture thereof.
MX9102325A MX9102325A (es) 1990-12-07 1991-12-02 Formas de dosis farmaceuticas de almacalante y procedimiento para su obtencion.
SK55693A SK55693A3 (en) 1990-12-07 1991-12-03 Solid dosage forms of almokalant and processes for manufacture thereof
HU9301670A HUT64217A (en) 1990-12-07 1991-12-03 Process for producing solide dosing forms of almocalant
PCT/SE1991/000815 WO1992010172A1 (en) 1990-12-07 1991-12-03 Solid dosage forms of almokalant and processes for manufacture thereof
EP91920708A EP0560821A1 (en) 1990-12-07 1991-12-03 Solid dosage forms of almokalant and processes for manufacture thereof
JP4500117A JPH06503312A (ja) 1990-12-07 1991-12-03 アルモカラントの固体剤形およびその調製方法
AU89307/91A AU8930791A (en) 1990-12-07 1991-12-03 Solid dosage forms of almokalant and processes for manufacture thereof
MA22639A MA22355A1 (fr) 1990-12-07 1991-12-03 Presentations solides de l'almokalant et procedes en vue de leur fabrication
CA002097178A CA2097178A1 (en) 1990-12-07 1991-12-03 Solid dosage forms of almokalant and processes for manufacture thereof
CS931037A CZ103793A3 (en) 1990-12-07 1991-12-03 Solid dosing forms of almocalant, and process for preparing thereof
PT99719A PT99719A (pt) 1990-12-07 1991-12-06 Processo para a preparacao de composicoes farmaceuticas solidas contendo 4-{3-{etil-3{-(propil-sulfinil)-propil}-amino}-2-hidroxipropoxi}-benzonitrilo (almokalant
TNTNSN91117A TNSN91117A1 (fr) 1990-12-07 1991-12-06 Presentations solides de l'almokalant et procedes en vue de leur fabrication
IS3788A IS3788A7 (is) 1990-12-07 1991-12-06 Aðferðir við framleiðslu lyfjaskammta í föstu formi sem innihalda almokalant
MYPI91002267A MY106776A (en) 1990-12-07 1991-12-06 Solid dosage forms of almokalant and processes for manufacture thereof.
CN91112789A CN1063039A (zh) 1990-12-07 1991-12-07 爱尔芒克雷特的固态剂型及其制法
NO93932052A NO932052L (no) 1990-12-07 1993-06-04 Faste doseringsformer av almokalant og fremgangsmaater forfremstilling derav
FI932554A FI932554A (fi) 1990-12-07 1993-06-04 Fasta doseringsformer av almokalant och foerfaranden foer framstaellning av daerav
BG97851A BG97851A (en) 1990-12-07 1993-06-04 Hard dosed forms of almocalante and method for obtaining them
LTIP1717A LTIP1717A (en) 1990-12-07 1993-12-30 Solid dosage forms of almokalant and process for manufacture thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003902A SE9003902D0 (sv) 1990-12-07 1990-12-07 Solid dosage forms of a drug

Publications (1)

Publication Number Publication Date
SE9003902D0 true SE9003902D0 (sv) 1990-12-07

Family

ID=20381121

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003902A SE9003902D0 (sv) 1989-06-20 1990-12-07 Solid dosage forms of a drug

Country Status (26)

Country Link
EP (1) EP0560821A1 (sv)
JP (1) JPH06503312A (sv)
CN (1) CN1063039A (sv)
AP (1) AP258A (sv)
AU (1) AU8930791A (sv)
BG (1) BG97851A (sv)
CA (1) CA2097178A1 (sv)
CZ (1) CZ103793A3 (sv)
FI (1) FI932554A (sv)
HU (1) HUT64217A (sv)
IE (1) IE914137A1 (sv)
IL (1) IL100150A0 (sv)
IS (1) IS3788A7 (sv)
LT (1) LTIP1717A (sv)
MA (1) MA22355A1 (sv)
MX (1) MX9102325A (sv)
MY (1) MY106776A (sv)
NZ (1) NZ240731A (sv)
PT (1) PT99719A (sv)
SE (1) SE9003902D0 (sv)
SK (1) SK55693A3 (sv)
TN (1) TNSN91117A1 (sv)
TW (1) TW215057B (sv)
WO (1) WO1992010172A1 (sv)
YU (1) YU186891A (sv)
ZA (1) ZA919264B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602757A1 (de) * 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP4504467B2 (ja) * 1998-07-30 2010-07-14 佐藤製薬株式会社 口腔内崩壊性錠剤
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8705150D0 (sv) * 1987-12-23 1987-12-23 Haessle Ab Novel antiarrhythmic agents
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
SE8902236D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel polystyrenesulfonate

Also Published As

Publication number Publication date
FI932554A (fi) 1993-06-08
FI932554A0 (fi) 1993-06-04
YU186891A (sh) 1994-04-05
CN1063039A (zh) 1992-07-29
HU9301670D0 (en) 1993-09-28
IL100150A0 (en) 1992-08-18
PT99719A (pt) 1992-10-30
MA22355A1 (fr) 1992-07-01
AU8930791A (en) 1992-07-08
TNSN91117A1 (fr) 1992-10-25
HUT64217A (en) 1993-12-28
AP258A (en) 1993-06-03
LTIP1717A (en) 1995-07-25
AP9100338A0 (en) 1992-01-31
NZ240731A (en) 1993-10-26
JPH06503312A (ja) 1994-04-14
SK55693A3 (en) 1993-10-06
BG97851A (en) 1994-04-29
EP0560821A1 (en) 1993-09-22
ZA919264B (en) 1992-08-26
IE914137A1 (en) 1992-06-17
IS3788A7 (is) 1992-06-08
MX9102325A (es) 1992-06-01
CZ103793A3 (en) 1994-02-16
MY106776A (en) 1995-07-31
CA2097178A1 (en) 1992-06-08
WO1992010172A1 (en) 1992-06-25
TW215057B (sv) 1993-10-21

Similar Documents

Publication Publication Date Title
FI913248A (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
NL194748B (nl) Osmotische doseringsvorm voor behandeling van cardiovasculaire ziekten.
SE8701900L (sv) Pulsavgivning av lekemedel
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
DE19975062I1 (de) Pharmazeutische Zusammensetzungen die N-substituierte 3-Hydroxypyrid-2-on-oder-4-on-Derivate enthalten
FI905684A0 (fi) Farmaceutisk doseringsform foer utdelning av medicin aot fiskar.
DE69133371D1 (de) Pharmazeutische wirksame Benzochinazolin Verbindungen
ES2024010B3 (es) Unidad de dosis farmaceutica.
DK173081A (da) Farmaceutisk produkt til oral administration indeholdende cytidindiphosphocholin
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
SE9003902D0 (sv) Solid dosage forms of a drug
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
DK559288D0 (da) Farmaceutisk praeparat for piperidinoalkanolderivater
YU44392A (sh) Postupak za dobijanje farmaceutske formulacije diritromicina
DK400887A (da) Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
NO910186L (no) Fremgangsmaate for fremstilling av et oralt inhalerbart, farmasoeytisk atropin-salbutamol-aerosolpreparat.
NO980384L (no) Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler
DK37589D0 (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
FI830245L (fi) Foerbaettringar beroerande via naesan intagbara farmaceutiska kompositioner
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.
JO1718B1 (en) Solid dosage form of Muclant drug and its manufacturing processes
SE9000288D0 (sv) New use